After assessing data from the first 46 adults with refractory nontuberculous mycobacterial lung disease who completed the ...

Amy Maxson felt like she was in the best shape of her life, until she couldn't catch her breath. A CT scan revealed it was ...

The "Nebulizer Market Share Analysis and Size - Growth Trends and Forecast Report 2025-2033" has been added to ResearchAndMarkets.com's offering. The Global Nebulizer Market is expected to reach US$ 2 ...

The Canadian singer behind some of the most tenderhearted songs of the late-‘90s - “I Will Remember You,” “Adia” and the ...

BiomX Inc (PHGE) progresses in clinical trials for BX004 and BX011, despite facing financial constraints and a temporary FDA ...

Operator: Good morning, and welcome to BiomX Third Quarter 2025 Financial Results and Program Update Conference Call.

Congress leader Dr. Shama Mohamed shared a video of herself from a hospital bed wearing a nebulizer mask to highlight the worsening air quality in Delhi on Tuesday. In her post on social media, she ...

Discusses Discontinuation of ICoN-1 Phase III Trial for Nebulized Clofazimine in NTM Lung Disease November 9:00 ...

A phase 3 trial evaluating a nebulized clofazimine inhalation suspension (MNKD-101) for the treatment of refractory nontuberculous mycobacterial (NTM) ...

Get the latest on BiomX Inc.'s Q3 2025 earnings, FDA feedback on phage therapies BX004 & BX011, clinical progress, and financial outlook.

Nurture the mind, body, and spirit this holiday season. Shop our top picks of exceptional at-home products designed to help ...

Positive FDA feedback confirms clear clinical pathway for BX011 targeting S. aureus in Diabetic Foot Infections, building on ...